Thomas O Daniel
CIK 1538894 · see remarks · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.2K
Companies
6
Total Filings
59
Lifetime Open-Market Net
-$31.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GOSS | Director | 38,095 | $0.16 | $6.2K | $0 | 9 | 2026-06-05 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Director | 101,926 | $11.19 | $1.14M | $0 | 5 | 2022-06-30 |
| LRMR | Director | — | $3.47 | — | $0 | 2 | 2021-05-17 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Director | 19,452 | — | — | $0 | 8 | 2019-06-27 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | — | — | — | $0 | 2 | 2018-03-07 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 68,965 | — | — | -$31.31M | 33 | 2015-12-18 |
Recent Filings · Page 2 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-18 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2020-06-09 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-27 | Larimar Therapeutics, Inc. (ZFGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-11 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2019-06-11 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-12 | GOSS | Conv (C) | +38,095 | $0 | EDGAR |
| 2019-01-28 | Larimar Therapeutics, Inc. (ZFGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-27 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Conv (C) | +24,527 | $0 | EDGAR |
| 2018-06-07 | Larimar Therapeutics, Inc. (ZFGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Disp (D) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.